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Abstract
Background: Dietary protein and amino acid intake and composition can modulate
immune function.
Objectives: To evaluate the effects of high-protein intake and arginine and ornithine
supplementation on feline immune cells.
Animals: Ten healthy cats.
Methods: Experimental study. Cats received a high-protein basal diet as a single daily
meal. A crossover design was applied with treatments being basal diet (w/o); basal
diet with arginine supplementation (+50, 75, 100% compared to the arginine provi-
sion by the basal diet; Arg 1-3); and basal diet with ornithine supplementation (+100,
150, 200% compared to the arginine provision by the basal diet; Orn 1-3). Blood
samples were collected at the end of each 11-day treatment period.
Results:Mitogen-stimulated proliferative activity of blood leukocytes revealed a qua-
dratic effect for the dietary supplementation of arginine (P = .02) and ornithine
(P = .03) (means for ConA-stimulation: w/o = 6.96; Arg 1 = 9.31; Arg 2 = 11.4; Arg
3 = 8.04; Orn 1 = 15.4; Orn 2 = 9.43; Orn 3 = 9.28; pooled SEM: 0.96). The number
(% gated) of phagocytic granulocytes linearly decreased with increasing dietary con-
centrations of arginine (P = .05) and ornithine (P = .03) (means: w/o = 95.5; Arg
1 = 93.0; Arg 2 = 92.5; Arg 3 = 92.6; Orn 1 = 92.6; Orn 2 = 92.6; Orn 3 = 91.5;
pooled SEM = 0.44).
Conclusions and Clinical Importance: This study could demonstrate immunomodu-
lating properties of dietary arginine and ornithine in cats.
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1 | INTRODUCTION
Specific amino acids can modulate the immune function,1 but there
is little data for cats. Supplementation of arginine to a low-protein
diet increases the proliferative and phagocytic activity of feline
leukocytes.2 Cytokine secretion and proliferative activity of the
feline T-cell line MYA-1 are enhanced by high doses of arginine in
the cell media.3
Abbreviations: ConA, concanavalin A; PHA-M, phytohemagglutinin; PWM, pokeweed mitogen.
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Since there is little information available on the effects of arginine
and ornithine in cats, the present study aimed at evaluating the dose-
dependent immunomodulating properties of these amino acids in
domestic cats.
2 | METHODS
2.1 | Study design
Ten healthy adult cats (4 female, intact cats, 6 male, neutered cats;
7.37 ± 2.00 years old) were included in this study. The study obtained
approval by the Animal Welfare Committee (Landesamt für Gesund-
heit und Soziales) in Berlin, Germany (G 0120/15).
The cats received a high-protein diet without (w/o) or with the
supplementation of arginine (+50%, +75% and +100% compared to
the arginine provision by the basal diet; Arg 1-3) and ornithine
(+100%, +150% and +200% compared to the arginine provision by
the basal diet; Orn 1-3), using a randomized crossover design. The
arginine concentration in the basal diet was 30.2 g/kg dry matter and
the ornithine concentration 1.81 g/kg dry matter. The analyzed crude
nutrient concentrations in the diets were (on a dry matter basis):
60.3% crude protein, 25.1% crude fat, 0.84% crude fiber, and 8.40%
crude ash. More details about the diets can be found elsewhere.4 The
supplements (arginine, ornithine) were mixed with the daily amount of
food. The cats were fed individually throughout the study in order to
assess their daily feed intake.
Diets were fed for 11 days each, with a 7-day wash-out period in
between, where only the basal diet was fed. The cats were housed in
groups on days 1-7 of each treatment period, as well as during the
wash-out periods. For the last 4 days of each treatment period, the cats
were housed individually in metabolic cages to collect urine and feces
(data not part of this study4). Blood was collected by routine cephalic
venipuncture on the last day of each treatment period at 6.00 hours in
the morning. For the present analyses, only fasting blood was used.
Blood was collected using potassium EDTA tubes (Micro tube K3E,
Sarstedt, Nümbrecht, Germany) for the differential blood count, and
lithium heparin tubes (S-Monovette, Sarstedt, Nümbrecht, Germany)
for the isolation of blood leukocytes (phenotyping, measurement of the
proliferative activity, and number of phagocytic blood cells).
2.2 | Blood analyses
For the analysis of the white blood cell count and differential blood
cell count, the Sysmex XT2000i (Sysmex Deutschland GmbH, Nor-
derstedt, Germany) was used.
Details on the methods for phenotyping and the measurement
of the proliferative activity and the number of phagocytic blood leu-
kocytes are described by Paßlack et al.5 In short, feline leukocytes
were labeled with primary antibodies (mouse anti-cat CD4:FITC
[Serotech;MCA1346F; 1:20 dilution], mouse anti-cat CD8ALPHA/BETA
[Serotech; MCA1347PE; 1:20 dilution]), mouse anti-canine CD21
[Serotech; MCA1781S; 1:100 dilution], mouse anti-human CD14:
FITC [Serotech; MCA1568F; 1:20 dilution], mouse anti-cat MHC Class II
[Serotech; MCA2723; 1:20 dilution], and P-DH59B, Specificity CD172a
[Monoclonal Antibody Center; P-BOV2049; 1:100 dilution]). Except for
the samples with mouse anti-cat CD4:FITC and mouse anti-cat
CD8ALPHA/BETA, the samples were additionally labeled with the
following secondary antibodies: Goat F(ab')2 anti-mouse IgG1-RPE,
Human adsorbed, Southern-Biotech, 1072-09 and goat anti-mouse
IgG2b-RPE, Human adsorbed, Southern-Biotech, 1090-09.
For the measurement of the proliferative activity, peripheral blood
mononuclear cells were stimulated with the mitogens pokeweed mito-
gen (PWM; concentration in the microplate well: 2.5 μg/mL), Conca-
navalin A (Con A; 5 μg/mL), and Phytohemagglutinin, M form (PHA-M;
10 μg/mL). Different mitogens were used, as not only different lympho-
cyte subpopulations are stimulated by these substances (T cells by PHA
and ConA, T and B cells by PWM6), but also to a varying extent. For
instance, a markedly higher stimulation of feline leukocytes has been
observed for ConA than for PHA-M.5
For the measurement of the number of phagocytic granulocytes and
monocytes in the blood of the cats, a commercial test kit (PHAGOTEST,
Glycotope Biotechnology GmbH, Heidelberg, Germany) was used.
All measurements were performed using the flow cytometer
MACSQuant (Miltenyi Biotec GmbH, Bergisch Gladbach, Germany).
2.3 | Statistical data analysis
The data were analyzed using IBM SPSS Statistics 22 (SPSS Inc, Chi-
cago, Illinois, 2013). A general linear model for repeated measures was
applied to calculate linear and quadratic polynomial contrasts. Polyno-
mial contrasts were calculated separately for the arginine and ornithine
treatment, with the within-subject factor arginine resp. ornithine, and a
number of levels = 4 (basal diet plus three [increasing] doses of arginine
resp. ornithine). The data are presented in tables as means and pooled
standard error of means (SEM). The level of significance was P ≤ .05.
3 | RESULTS
3.1 | Health status and food intake
All cats were clinically healthy throughout the study. The diets did not
affect the feed intake or body weight of the animals (data not shown,
but published elsewhere4). The daily feed intake (% of the amount
offered) was: 93.4% (w/o), 88.9% (Arg 1), 89.6% (Arg 2), 88.3% (Arg
3), 90.7% (Orn 1), 90.9% (Orn 2), and 92.1% (Orn 3) (SEM: 1.15%) (lin-
ear contrast for arginine: P = .15, quadratic contrast for arginine:
P = .39, linear contrast for ornithine: P = .53, quadratic contrast for
ornithine: P = .32).
As the supplements were mixed with the daily amount of food,
but the remainder was not analyzed for the nitrogen concentration,
the daily crude protein intake of the cats can only be calculated based
on the intake of the basal diet and without regard to the additional
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nitrogen intake by the supplements. The daily crude protein intake
(per kilogram body weight and day) of the cats was 6975 mg (w/o),
6719 mg (Arg 1), 6697 mg (Arg 2), 6717 mg (Arg 3), 6830 mg (Orn 1),
6787 mg (Orn 2), and 6910 mg (Orn 3) (SEM: 118 mg) (linear contrast
for arginine: P = .23, quadratic contrast for arginine: P = .22, linear con-
trast for ornithine: P = .62, quadratic contrast for ornithine: P = .36).
As published previously, the postprandial, but not the fasting
blood urea concentrations' are above the reference range.4
3.2 | White blood cells and differential blood
count
The dietary supplementation of arginine and ornithine had no effect
on the white blood cell count (%) of the cats (Table 1). In some treat-
ment groups, the absolute cell number of blood lymphocytes and
monocytes was above the reference value. However, when the rela-
tive cell number (% of white blood cells) was considered, no increase
of lymphocytes or monocytes could be detected.
All groups had eosinophilic granulocytes in the blood, both for
the absolute and relative cell numbers above the reference range. An
exception being the group with the highest arginine supplementation,
where the percentage of blood eosinophils was within the reference
range.
3.3 | Leukocyte subpopulations
The dietary supplementation of arginine and ornithine did not affect
the numbers (% gated) of T cells, B cells, myeloid cells, or antigen-
presenting cells (Table 2).
3.4 | Mitogen-stimulated proliferative activity
of blood leukocytes
The stimulation with the mitogen PHA-M had no effect on the prolif-
erative activity of blood leukocytes (Table 3). The dietary supplements
first increased the proliferative activity of the leukocytes after stimu-
lation with ConA (arginine, ornithine) and PWM (ornithine), but subse-
quently decreased their activity at higher supplementation doses
(quadratic effects; P < .05).
3.5 | Number of phagocytic blood monocytes
and granulocytes
Increasing doses of arginine and ornithine decreased the number of
phagocytic blood granulocytes (linear contrasts; P < .05), but did not
affect the number of phagocytic blood monocytes (Table 4).
TABLE 1 White blood cells and differential blood count of cats fed a high-protein diet without (w/o) or with arginine (Arg) or ornithine (Orn)
supplementationa
P values (polynomial contrasts)
Arg Orn Arg Orn
w/o Arg 1 Arg 2 Arg 3 Orn 1 Orn 2 Orn 3 SEM Linear Quadratic Linear Quadratic
White blood cells (G/l) 14.3 15.8 15.2 14.8 15.3 14.7 13.6 0.42 .82 .23 .38 .07
G/l
Neutrophilic granulocytes 8.88 9.07 9.45 9.63 9.76 8.79 8.51 0.30 .61 .44 .45 .25
Lymphocytes 3.87 4.90 3.76 3.78 4.07 4.48 3.81 0.15 .02 .10 .75 .29
Monocytes 0.46 0.61 0.58 0.61 0.51 0.51 0.40 0.03 .41 .36 .24 .05
Eosinophilic granulocytes 1.06 1.11 1.06 0.77 0.97 0.95 0.87 0.07 .04 .36 .12 .96
Basophilic granulocytes 0.01 0.02 0.02 0.02 0.02 0.02 0.02 0.00 .68 .05 .82 .11
Percentage of white blood cells
Neutrophilic granulocytes 62.2 57.8 63.3 64.5 62.7 60.1 62.1 0.73 .13 .08 .71 .74
Lymphocytes 27.3 31.0 25.9 25.9 27.5 30.1 28.4 0.73 .29 .30 .34 .61
Monocytes 3.24 3.76 3.89 4.17 3.30 3.49 3.06 0.15 .05 .91 .74 .38
Eosinophilic granulocytes 7.25 7.03 6.83 5.30 6.31 6.18 6.23 0.42 .07 .65 .25 .28
Basophilic granulocytes 0.09 0.13 0.11 0.11 0.15 0.11 0.12 0.01 .48 .17 .52 .24
Notes: Mean and pooled SEM. Reference values (G/L)7: white blood cells: 6-11 (18; when excited); neutrophilic granulocytes: 3-11; lymphocytes: 1–4;
monocytes: 0.04-0.5; eosinophilic granulocytes: 0.04-0.6; basophilic granulocytes: 0-0.1.
Reference values (% of white blood cells)7: neutrophilic granulocytes: 60-78%; lymphocytes: 15-38%; monocytes: 0-4%; eosinophilic granulocytes: 0-6%;
basophilic granulocytes: 0-1%.
aArginine supplementation (Arg 1-3): +50%, +75%, and +100% compared to the arginine provision by the basal diet; ornithine supplementation (Orn 1-3):
+100%, +150%, and +200% compared to the arginine provision by the basal diet.
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4 | DISCUSSION
The dietary supplementation of arginine and ornithine could demon-
strate immunomodulating effects in cats. While the impact of the sup-
plements on the proliferative activity of blood leukocytes was less
clear, the linear decrease of phagocytic blood granulocytes with
increasing amounts of arginine and ornithine in the diet revealed a sig-
nificant dose-dependent effect.
The results contrast with data previously observed in cats, where
a dietary arginine supplementation led to an increase of the
TABLE 2 Phenotyping of blood leukocytes of cats fed a high-protein diet without (w/o) or with arginine (Arg) or ornithine (Orn) supplementationa
P values (polynomial contrasts)
Arg Orn Arg Orn
w/o Arg 1 Arg 2 Arg 3 Orn 1 Orn 2 Orn 3 SEM Linear Quadratic Linear Quadratic
In % gated
CD4+CD8− 31.8 33.5 32.5 31.5 30.9 35.8 32.6 0.77 .95 .08 .16 .33
CD4+CD8+ 1.18 1.58 0.61 2.10 2.43 1.92 0.93 0.38 .55 .83 .58 .41
CD4−CD8+ 18.1 18.9 16.2 16.1 16.3 17.7 17.5 0.69 .93 .37 .79 .26
MHCII+ 87.4 88.0 86.8 85.8 85.5 86.6 86.0 0.72 .87 .52 .87 .40
SWC3+ 98.0 97.3 97.3 98.0 97.1 98.1 96.4 0.31 .93 .94 .47 .64
CD14+ 13.9 12.5 15.0 14.9 13.5 12.7 12.0 0.65 .38 .96 .11 .82
CD21+ 23.6 22.1 22.4 21.4 23.1 20.3 20.9 0.90 .32 .33 .08 .50
Notes: Mean and pooled SEM. CD4+CD8− and CD4+CD8+: T-helper cells; CD4−CD8+: cytolytic T cells; MHCII+: antigen-presenting cells; SWC3+ and
CD14+: myeloid cells; CD21+: B cells.
aArginine supplementation (Arg 1–3): +50%, +75%, and +100% compared to the arginine provision by the basal diet; ornithine supplementation (Orn 1-3):
+100%, +150%, and +200% compared to the arginine provision by the basal diet.
TABLE 3 Proliferative activitya of lymphocytes of cats fed a high-protein diet without (w/o) or with arginine (Arg) or ornithine (Orn) supplementationb
P values (polynomial contrasts)
Arg Orn Arg Orn
Mitogen stimulation w/o Arg 1 Arg 2 Arg 3 Orn 1 Orn 2 Orn 3 SEM Linear Quadratic Linear Quadratic
PWM 4.75 6.03 6.19 5.15 7.08 6.53 5.16 0.44 .77 .27 .90 .05
ConA 6.96 9.31 11.4 8.04 15.4 9.43 9.28 0.96 .50 .02 .92 .03
PHA-M 2.58 2.58 2.89 2.22 3.56 2.90 3.58 0.26 .81 .49 .46 .80
Notes: Mean and pooled SEM.
Abbreviations: ConA, Concanavalin A; PHA-M: Phytohemagglutinin, M form; PWM, pokeweed mitogen.
aCalculation of the proliferation index: proliferative activity of stimulated lymphocytes (% gated)/proliferative activity of unstimulated lymphocytes
(% gated).
bArginine supplementation (Arg 1-3): +50%, +75%, and +100% compared to the arginine provision by the basal diet; ornithine supplementation (Orn 1-3):
+100%, +150%, and +200% compared to the arginine provision by the basal diet.
TABLE 4 Number of phagocytic blood monocytes and granulocytes of cats fed a high-protein diet without (w/o) or with arginine (Arg) or ornithine
(Orn) supplementationa
P values (polynomial contrasts)
Arg Orn Arg Orn
w/o Arg 1 Arg 2 Arg 3 Orn 1 Orn 2 Orn 3 SEM Linear Quadratic Linear Quadratic
Percentage gated
Phagocytic monocytes 76.8 71.7 74.2 73.5 72.1 71.4 71.5 0.89 0.54 .40 .07 .28
Phagocytic granulocytes 95.5 93.0 92.5 92.6 92.6 92.6 91.5 0.44 0.050 .28 .03 .46
Notes: Mean and pooled SEM.
aArginine supplementation (Arg 1–3): +50%, +75%, and +100% compared to the arginine provision by the basal diet; ornithine supplementation (Orn 1-3):
+100%, +150%, and +200% compared to the arginine provision by the basal diet.
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proliferative and phagocytic activity of blood leukocytes.2 In addition,
an in vitro study could also demonstrate stimulating effects of high
arginine concentrations in the cell media (up to the 8-fold arginine
blood concentration) on the proliferative activity and cytokine secre-
tion of feline T cells.3 Importantly, in the study of Rutherfurd-
Markwick et al,2 a low-protein diet (22.7% in dry matter) was offered
and only a single dose of arginine (1.9% in dry matter) was tested. In
the present study, markedly higher protein (and arginine) intakes were
evaluated in cats. Therefore, differences in the study design and die-
tary regimen might explain the different outcomes of the studies.
With regard to the potential clinical relevance of the decreased num-
ber of phagocytic blood granulocytes observed at high arginine and
ornithine supplementation, it should be considered that the effects
were relatively small, as the cell numbers were reduced by 3%-4%. In
general, it can be concluded that both, arginine and ornithine revealed
immunomodulating properties. As arginine is the precursor of
ornithine,8 it is interesting to notice that the effects of both amino
acids were comparable, but slightly more pronounced for ornithine.
This could be possibly attributed to the higher doses considered for
this amino acid.
For the interpretation of the detected effects of dietary arginine
and ornithine, it should finally be considered that the protein and
therefore amino acid concentration in the basal diet was already high
and above maintenance requirements. The effects of an additional
supplementation of arginine or ornithine might be more pronounced
when feeding a low-protein diet, where the baseline intake of these
amino acids is low. As an alternative, it is also possible that a low-
protein diet would require even higher doses of arginine or ornithine
supplementation to achieve comparable results as observed in the
present study. This aspect should be clarified in future
investigations.
It is a limitation of the present investigation that no low- or
moderate-protein diet has been included in this feeding study as another
control diet. This might have had further advantages for data interpreta-
tion, particularly for comparing the observed effects of a high-protein
intake in principal. However, as especially the effects of a dietary arginine
and ornithine supplementation were evaluated in the present study, it
was most important to have the same diet, but without the supplements,
as a control diet. In addition, the effects of increasing protein levels in a
diet for cats have already been described,5 why the present study did
not focus on this aspect in general.
5 | CONCLUSION
The dietary supplementation of arginine and ornithine revealed
immunomodulating properties of these amino acids in cats, as the pro-
liferative activity and number of phagocytic blood leukocytes were
affected. These findings should be further evaluated, particularly in dis-
eased cats with an impaired or even exaggerated immune response.
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